Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serine protease 59, pseudogene (PRSS59P) is classified as a pseudogene related to the trypsin-like serine protease family. Unlike canonical serine proteases, such as trypsin and chymotrypsin, which are enzymes that catalyze the hydrolysis of peptide bonds and are involved in functions like digestion, blood coagulation, and immune response[2][3], PRSS59P is non-coding and does not produce an active enzyme. Pseudogenes like PRSS59P often originate from gene duplication or retrotransposition events followed by mutations that render them non-functional. While genuine serine proteases are thoroughly studied in biochemistry and molecular biology for their enzymatic activity, substrate specificity, and physiological roles, PRSS59P does not play any known biological or therapeutic role. Key considerations: - This entry is not a therapeutic target: it does not encode a protein, enzyme, receptor, or druggable entity. - The designation as "serine protease" in its name reflects its homology to active enzymes in the trypsin family, but its pseudogene status means it is not expressed as a functional protein. - There are no drugs, disease relevance, safety issues, or biomarkers associated with PRSS59P, as it is not expressed nor functional. - The name is sometimes confused with genuine serine protease targets, so care should be taken in databases and research contexts to distinguish pseudogenes from their active counterparts. Data justification: PRSS59P is listed and named as a pseudogene related to the serine protease S1 family (trypsin-like proteases), but none of the searchable literature, protein structure databases, or drug databases list it as a therapeutic target or active protein. Canonical serine proteases, by comparison, have well-established roles in biochemistry and medicine[2][3]. The most authoritative molecular databases, including NCBI Gene and UniProt, categorize PRSS59P under pseudogenes, confirming it is non-coding and non-functional.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serine protease 59, pseudogene (PRSS59P).